Evidence map›Paper›PMID 31611355›Full record

ArticleAntimicrobial agents and chemotherapy2019

Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral Reservoirs.

Aaron S Devanathan, Jason R Pirone, Ramesh Akkina, Leila Remling-Mulder, Paul Luciw, Lourdes Adamson, J Victor Garcia, Martina Kovarova, Nicole R White, Amanda P Schauer and 6 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Enhancing the Sensitivity of Mass Spectrometry Imaging through Spatial Signal Averaging.Journal of the American Society for Mass Spectrometry · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Pharmacology of HIV Cure: Site of Action.Clinical pharmacology and therapeutics · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Aaron S DevanathanUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.ORCID 0000-0002-2778-3725
Jason R PironeUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Ramesh AkkinaColorado State University, Fort Collins, Colorado, USA.
Leila Remling-MulderColorado State University, Fort Collins, Colorado, USA.
Paul LuciwUniversity of California, Davis, Davis, California, USA.
Lourdes AdamsonUniversity of California, Davis, Davis, California, USA.
J Victor GarciaUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Martina KovarovaUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Nicole R WhiteUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Amanda P SchauerUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Kimberly BlakeUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Craig SykesUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Erin M BurgunderUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Nithya SrinivasUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Elias P RosenUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Angela D M KashubaUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA akashuba@unc.edu.

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation SupplementT32GM086330 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIM L.R. BROUWER, Daniel Gonzalez · 2011 to 2026
$8.5M
Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue ReservoirsR01AI111891 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KASHUBA, ANGELA D · 2014 to 2018
$4.3M
Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal TissuesU01AI095031 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KASHUBA, ANGELA D · 2011 to 2013
$2.4M
NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI111891NIAID NIH HHS U01 AI095031NIGMS NIH HHS T32 GM086330NIH HHS P51 OD011107NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100929NIMH NIH HHS U24 MH100930NIMH NIH HHS U24 MH100931
6 · The paper itself

Abstract

For HIV cure strategies like "kick and kill" to succeed, antiretroviral (ARV) drugs must reach effective concentrations in putative viral reservoirs. We characterize penetration of six ARVs in three preclinical animal models and humans. We found that standard dosing strategies in preclinical species closely mimicked tissue concentrations in humans for some, but not all, ARVs. These results have implications for interpreting HIV treatment, prevention, or cure interventions between preclinical and clinical models.

Indexed as

AnimalsAnti-HIV AgentsAnti-Retroviral AgentsAtazanavir SulfateEmtricitabineFemaleHIV InfectionsHumansIn Vitro TechniquesMaravirocMiceRaltegravir PotassiumTenofovirAnti-HIV AgentsAnti-Retroviral AgentsAtazanavir SulfateEmtricitabineMaravirocRaltegravir PotassiumTenofovirantiretroviralsHIVpharmacokineticsspecies differencestissue reservoirs

Identifiers

PMID31611355
PMCPMC7187610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.